SE7614265L - Beta-lactamantibiotika - Google Patents

Beta-lactamantibiotika

Info

Publication number
SE7614265L
SE7614265L SE7614265A SE7614265A SE7614265L SE 7614265 L SE7614265 L SE 7614265L SE 7614265 A SE7614265 A SE 7614265A SE 7614265 A SE7614265 A SE 7614265A SE 7614265 L SE7614265 L SE 7614265L
Authority
SE
Sweden
Prior art keywords
carbon atoms
beta
alkyl
lactamantibiotics
hydroxyl
Prior art date
Application number
SE7614265A
Other languages
English (en)
Swedish (sv)
Inventor
E Hunt
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7614265L publication Critical patent/SE7614265L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7614265A 1976-01-27 1976-12-17 Beta-lactamantibiotika SE7614265L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2976/76A GB1515241A (en) 1976-01-27 1976-01-27 Beta-lactam antibiotics

Publications (1)

Publication Number Publication Date
SE7614265L true SE7614265L (sv) 1977-07-28

Family

ID=9749578

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7614265A SE7614265L (sv) 1976-01-27 1976-12-17 Beta-lactamantibiotika

Country Status (10)

Country Link
US (1) US4093626A (de)
JP (1) JPS5291890A (de)
BE (1) BE850593A (de)
CH (1) CH635589A5 (de)
DE (1) DE2702091A1 (de)
DK (1) DK31877A (de)
FR (1) FR2339615A1 (de)
GB (1) GB1515241A (de)
NL (1) NL7700818A (de)
SE (1) SE7614265L (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1078465B (it) * 1976-06-08 1985-05-08 Glaxo Lab Ltd Composti fungicidi per agricoltura composizioni che li contengono e procedimento per produrli
US4529734A (en) * 1976-06-08 1985-07-16 Glaxo Laboratories Limited 2-Formyloxymethyl-clavam
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DE2860640D1 (en) * 1977-07-23 1981-08-06 Beecham Group Ltd Beta-lactam compounds, preparation and use in pharmaceutical compositions and as chemical intermediates
US4275067A (en) * 1977-09-14 1981-06-23 Beecham Group Limited Decarboxyclavulanic acid thio ethers, their preparation and use
US4202819A (en) * 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
EP0053893B1 (de) * 1980-12-09 1985-03-20 Beecham Group Plc Clavulansäure-Derivate, ihre Herstellung und ihre Verwendung
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
EP0057664A3 (de) * 1981-01-30 1982-11-17 Ciba-Geigy Ag Clavam-Derivate
GB9214603D0 (en) * 1992-07-09 1992-08-19 Taiho Pharmaceutical Co Ltd 4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as antitumor agents
GB9400220D0 (en) * 1994-01-07 1994-03-02 Taiho Pharmaceutical Co Ltd Novel 3-(substituted methyl)-4-oxa-1-azabicycle (3.2.0) heptan-7-one derivatives useful as antitumor agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
NL7402539A (de) * 1973-03-13 1974-09-17
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
NL7700818A (nl) 1977-07-29
BE850593A (fr) 1977-07-20
FR2339615A1 (fr) 1977-08-26
CH635589A5 (de) 1983-04-15
US4093626A (en) 1978-06-06
GB1515241A (en) 1978-06-21
JPS5291890A (en) 1977-08-02
FR2339615B1 (de) 1980-12-19
DE2702091A1 (de) 1977-07-28
DK31877A (da) 1977-07-28

Similar Documents

Publication Publication Date Title
SE8401134D0 (sv) Forfarande for framstellning av dihydro-cyklosporin d
GB1058606A (en) Novel hydroquinone derivatives for use as photographic developing agents
FR2367741A1 (fr) Nouveaux mercaptoacylamino-acides
SE7907121L (sv) Ftalimidinderivat
FR2416222A1 (fr) Derives perfluoroalkyl-thioethyl-ether
SE7614265L (sv) Beta-lactamantibiotika
FI73969B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva trans-4-aminometylcyklohexankarboxylsyraderivat.
FI822871A0 (fi) Nya 6 -metylprednisolonderivat, deras framstaellning och anvaendning
FR2389629A1 (de)
DE3061903D1 (en) Maytansinoids, their production and therapeutic compositions containing them
FR2383185A1 (de)
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
SE7910072L (sv) Pyrrolo- eller pyrido(2,1-c)(1,4)tiaziner eller -tiazepiner
DK211283A (da) Benzothiazolinforbindelser
FR2367743A1 (fr) Derives aryle conten
ES8105976A1 (es) Procedimiento para la preparacion de acilureas
AU536912B2 (en) Benzothiazole derivatives
SE7607088L (sv) 5-fluor-uracilderivat.
FR2357558A1 (fr) 2,6-methano-2h-1-benzoxocines
FI810145L (fi) Nya substituerade 1,8-dihydroxi-9-(10h)antracenoner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
GB2005246A (en) beta -Lactam compounds and processes for their preparation
FR2426688A1 (fr) Nouvelles neplanocines antibiotiques
SE7805863L (sv) Rifamycinforeningar
FI820240L (fi) Nytt framstaellningsfoerfarande foer 17alfa-hydroxi-17beta-hydroxiacetylsteroider och pao motsvarande saett erhaollna mellanprodukter

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7614265-2

Format of ref document f/p: F